Breaking News Instant updates and real-time market news.

NAVB

Navidea

$0.80

0.0359 (4.67%)

, CAH

Cardinal Health

$70.55

0.42 (0.60%)

17:44
11/23/16
11/23
17:44
11/23/16
17:44

On The Fly: After Hours Movers

HIGHER: Navidea (NAVB), up 25.5%, extending gains after hours following its asset purchase agreement with Cardinal Health (CAH)... Insteel (IIIN), up 5.5% after it was named to replace Littlefuse (LFUS) in the S&P 600. LOWER: Corbus Pharmaceuticals (CRBP), down 6.3% after entering a controlled equity offering sales agreement with Cantor Fitzgerald... Airgain (AIRG), down 5% after it announced the release of lock up restrictions on common stock.

NAVB

Navidea

$0.80

0.0359 (4.67%)

CAH

Cardinal Health

$70.55

0.42 (0.60%)

IIIN

Insteel

$36.58

0.76 (2.12%)

LFUS

Littelfuse

$149.72

2.81 (1.91%)

CRBP

Corbus Pharmaceuticals

$8.00

0.05 (0.63%)

AIRG

Airgain

$26.95

0.2 (0.75%)

  • 28

    Nov

  • 29

    Nov

  • 29

    Nov

  • 07

    Dec

  • 09

    Dec

NAVB Navidea
$0.80

0.0359 (4.67%)

CAH Cardinal Health
$70.55

0.42 (0.60%)

10/28/16
BARD
10/28/16
DOWNGRADE
BARD
Neutral
Cardinal Health downgraded to Neutral from Outperform at Baird
10/28/16
BARD
10/28/16
DOWNGRADE
Target $82
BARD
Neutral
Cardinal Health downgraded to Neutral at Baird
As reported previously, Baird analyst David Coldwell downgraded Cardinal Health (CAH) to Neutral from Outperform as aggressive competition is trying to recapture pharmacy share and the company will have to defend its pharmacy base. Coldwell lowered his price target to $82 from $92 on Cardinal Health shares, which are down over 6% to $70 in pre-market trading following a downbeat quarterly report and cautious guidance last night from peer McKesson (MCK).
10/10/16
CLVD
10/10/16
DOWNGRADE
CLVD
Neutral
Cardinal Health downgraded to Neutral from Buy at Cleveland Research
10/05/16
UBSW
10/05/16
INITIATION
Target $82
UBSW
Neutral
Cardinal Health initiated with a Neutral at UBS
Target $82.
IIIN Insteel
$36.58

0.76 (2.12%)

04/01/16
SIDC
04/01/16
DOWNGRADE
SIDC
Neutral
Insteel downgraded to Neutral from Buy at Sidoti
Sidoti downgraded Insteel to Neutral citing a PC strand capacity increase from a competitor and maintained its $32 price target on shares.
11/22/16
SIDC
11/22/16
UPGRADE
Target $44
SIDC
Buy
Insteel upgraded to Buy from Neutral at Sidoti
Sidoti upgraded Insteel to Buy and raised its price target to $44 from $32 siting increased wire rod prices.
LFUS Littelfuse
$149.72

2.81 (1.91%)

11/21/16
SIDC
11/21/16
DOWNGRADE
Target $157
SIDC
Neutral
Littelfuse downgraded to Neutral from Buy at Sidoti
Sidoti downgraded Littelfuse to Neutral citing the recent rise in shares and maintained its $157 price target.
09/08/16
BARD
09/08/16
NO CHANGE
Target $132
BARD
Outperform
Littelfuse investors should be aggressive on pullbacks, says Baird
Baird analyst Timothy Wojs met with Littlefuse management and came away more confident that shares should be bought aggressively on any pullbacks. The analyst continues to like the long-term risk/reward given the company's relatively solid organic growth and execution as well as recent M&A activity, which had provided some upside bias to numbers over time. Wojs reiterated his Outperform rating and $132 price target on Littlefuse shares.
09/13/16
OPCO
09/13/16
NO CHANGE
Target $145
OPCO
Outperform
Littelfuse price target raised to $145 from $138 at Oppenheimer
Oppenheimer analyst Christopher Glynn raised his price target for Littelfuse to $145 from $138, citing liquidity, acquisition track record, and underlying earnings power runway on portfolio integration. The analyst continues to view shares of Littelfuse as his top pick for strategy deployment and compounding runway over the next several years. He reiterates an Outperform rating on the shares.
10/28/16
OPCO
10/28/16
NO CHANGE
Target $155
OPCO
Outperform
Littelfuse price target raised to $155 from $145 at Oppenheimer
Oppenheimer analyst Christopher Glynn raised his price target for Littelfuse to $155 from $145 after the company raised its Q3 guidance. The analyst reiterates an Outperform rating on the shares.
CRBP Corbus Pharmaceuticals
$8.00

0.05 (0.63%)

10/04/16
CANT
10/04/16
INITIATION
Target $17
CANT
Buy
Corbus Pharmaceuticals initiated with a Buy at Cantor
Cantor initiated Corbus Pharmaceuticals with a Buy and a $17 price target.
11/15/16
JMPS
11/15/16
NO CHANGE
JMPS
Corbus Pharmaceuticals price target raised to $20 from $9 at JMP Securities
JMP Securities analyst Liisa Bayko raised her price target on Corbus as she believes that data on the company's Resunab drug for scleroderma indicates that its efficacy could be significantly positive, while its safety/tolerability could be "favorable." Bayko keeps an Outperform rating on the shares.
09/19/16
AGIS
09/19/16
NO CHANGE
Target $12
AGIS
Buy
Corbus Pharmaceuticals price target raised to $12 from $7 at Aegis
Aegis analyst Robert Leboyer raised his price target for Corbus Pharmaceuticals to $12 from $7 and keeps a Buy rating on the name.
10/25/16
NBLE
10/25/16
NO CHANGE
NBLE
Corbus Pharmaceuticals risk/reward remains favorable, says Noble Financial
Noble Financial analyst Kumaraguru Raja remains bullish on Corbus' Resunab being developed for treating inflammation and fibrosis as it preferentially targets CB2 receptor; saying preliminary positive data in healthy volunteers validates role in inflammation resolution. The analyst said Resunab has better anti-inflammatory activity even in low doses adn the open-label extension indicates the FDA comfort with safety and efficacy. Raja likes Corbus' risk/reward heading into multiple data readouts and reiterates his Buy rating and $19 price target on shares.
AIRG Airgain
$26.95

0.2 (0.75%)

09/21/16
WDLK
09/21/16
DOWNGRADE
Target $14
WDLK
Hold
Airgain downgraded to Hold from Buy at Wunderlich
Wunderlich analyst Matthew Robison downgraded Airgain to Hold with a $14 price target following the company's Q2 results.
10/31/16
WDLK
10/31/16
UPGRADE
WDLK
Buy
Airgain upgraded to Buy from Hold at Wunderlich
Wunderlich analyst Matthew Robison upgraded Airgain to Buy.
10/31/16
WDLK
10/31/16
UPGRADE
Target $16
WDLK
Buy
Airgain upgraded to Buy on recent pullback at Wunderlich
Wunderlich analyst Matthew Robison upgraded Airgain to Buy from Hold saying the recent pullback in shares has created an attractive entry point. The company's business continues to progress, Robison tells investors in a research note. He raised his price target for the shares to $16 from $14.
09/06/16
NORL
09/06/16
INITIATION
Target $15
NORL
Outperform
Airgain initiated with an Outperform at Northland
Northland analyst Tom Sepenzis initiated Airgain with an Outperform rating and $15 price target.

TODAY'S FREE FLY STORIES

MDC

M.D.C. Holdings

$31.73

0.11 (0.35%)

17:10
09/21/17
09/21
17:10
09/21/17
17:10
Hot Stocks
M.D.C. Holdings announces Richmond American Homes enters Oregon Market »

M.D.C. Holdings announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VSAR

Versartis

$21.60

-0.25 (-1.14%)

17:09
09/21/17
09/21
17:09
09/21/17
17:09
Hot Stocks
Versartis down 85% after Phase 3 of somavaratan did not meet primary endpoint »

In after-hours trading,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IART

Integra LifeSciences

$48.31

-0.58 (-1.19%)

17:05
09/21/17
09/21
17:05
09/21/17
17:05
Hot Stocks
Integra LifeSciences enrolls first patient in Cadence ankle system study »

Integra LifeSciences has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

TIF

Tiffany

$89.85

-0.08 (-0.09%)

, RL

Ralph Lauren

$88.48

-0.63 (-0.71%)

17:04
09/21/17
09/21
17:04
09/21/17
17:04
Hot Stocks
Tiffany names Roger Farah as Chairman of Board, effective October 2 »

Tiffany & Co. (TIF)…

TIF

Tiffany

$89.85

-0.08 (-0.09%)

RL

Ralph Lauren

$88.48

-0.63 (-0.71%)

M

Macy's

$21.16

-0.32 (-1.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 04

    Oct

VSAR

Versartis

$21.60

-0.25 (-1.14%)

17:00
09/21/17
09/21
17:00
09/21/17
17:00
Hot Stocks
Breaking Hot Stocks news story on Versartis 

Versartis trading resumes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FLS

Flowserve

$42.19

-0.19 (-0.45%)

16:57
09/21/17
09/21
16:57
09/21/17
16:57
Hot Stocks
Flowserve appoints Lee Eckert as CFO »

Flowserve has named Lee…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AIG

AIG

$60.50

0.38 (0.63%)

16:57
09/21/17
09/21
16:57
09/21/17
16:57
Periodicals
Regulators weigh removing SIFI 'tag' from insurer AIG, Dow Jones says »

According to the report,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACM

Aecom

$34.94

-0.06 (-0.17%)

16:54
09/21/17
09/21
16:54
09/21/17
16:54
Hot Stocks
Aecom announces capital allocation policy and $1B stock repurchase authorization »

Aecom announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALOG

Analogic

$79.95

2.35 (3.03%)

16:49
09/21/17
09/21
16:49
09/21/17
16:49
Hot Stocks
Analogic achieves ECAC standard C2 for new cabin baggage screening solution »

Analogic announced its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMP

Compass Minerals

$69.50

-0.45 (-0.64%)

16:39
09/21/17
09/21
16:39
09/21/17
16:39
Earnings
Compass Minerals lowers FY17 EPS view to $2.50-$2.80 from $3.00-$3.50 »

Consensus is $3.02. The…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Sep

  • 29

    Sep

MDU

MDU Resources

$26.21

-0.19 (-0.72%)

16:39
09/21/17
09/21
16:39
09/21/17
16:39
Hot Stocks
MDU Resources names Jason Vollmer CFO, Stephanie Barth CAO »

MDU Resources announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:36
09/21/17
09/21
16:36
09/21/17
16:36
General news
Money Supply M2 Weekly Change data reported »

Week of 9/11 Money Supply…

16:36
09/21/17
09/21
16:36
09/21/17
16:36
General news
Fed Balance Sheet Level data reported »

Week of 9/20 Fed Balance…

TXN

Texas Instruments

$86.05

0.22 (0.26%)

16:35
09/21/17
09/21
16:35
09/21/17
16:35
Hot Stocks
Texas Instruments raises dividend 24%, adds to repurchase program »

Texas Instruments…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VSAR

Versartis

$21.60

-0.25 (-1.14%)

16:34
09/21/17
09/21
16:34
09/21/17
16:34
Hot Stocks
Versartis' somavaratan did not meet primary endpoint in Phase 3 trial »

Versartis announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FMC

FMC Corporation

$90.44

-1.51 (-1.64%)

, DWDP

DowDuPont

$70.32

-0.09 (-0.13%)

16:34
09/21/17
09/21
16:34
09/21/17
16:34
Hot Stocks
FMC Corporation cleared for proposed acquisition of DuPont Crop Protection unit »

FMC Corporation (FMC)…

FMC

FMC Corporation

$90.44

-1.51 (-1.64%)

DWDP

DowDuPont

$70.32

-0.09 (-0.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

MCD

McDonald's

$159.03

-0.85 (-0.53%)

16:32
09/21/17
09/21
16:32
09/21/17
16:32
Hot Stocks
McDonald's increases quarterly dividend 7% »

McDonald's board…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

16:30
09/21/17
09/21
16:30
09/21/17
16:30
Options
Preliminary option volume of 13.2M today »

Preliminary option volume…

TGI

Triumph Group

$27.85

-0.2 (-0.71%)

, BA

Boeing

$256.04

0.58 (0.23%)

16:27
09/21/17
09/21
16:27
09/21/17
16:27
Hot Stocks
Triumph Group signs contract extensions with Boeing for ducting, floor panels »

Triumph Group (TGI)…

TGI

Triumph Group

$27.85

-0.2 (-0.71%)

BA

Boeing

$256.04

0.58 (0.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

YOGA

YogaWorks

$4.00

-0.04 (-0.99%)

16:25
09/21/17
09/21
16:25
09/21/17
16:25
Earnings
YogaWorks sees Q3 revenue $12.7M-$13.2M, consensus $12.9M »

For the third quarter of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

VSAR

Versartis

$21.60

-0.25 (-1.14%)

16:25
09/21/17
09/21
16:25
09/21/17
16:25
Hot Stocks
Breaking Hot Stocks news story on Versartis »

Versartis trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

YOGA

YogaWorks

$4.00

-0.04 (-0.99%)

16:22
09/21/17
09/21
16:22
09/21/17
16:22
Earnings
YogaWorks reports Q2 adjusted net loss $3.1M vs. adjusted net loss $2.7M in Q216 »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

CSII

Cardiovascular Systems

$27.63

0.38 (1.39%)

16:20
09/21/17
09/21
16:20
09/21/17
16:20
Initiation
Cardiovascular Systems initiated  »

Cardiovascular Systems…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIX

Volatility Index S&P 500 Options

16:20
09/21/17
09/21
16:20
09/21/17
16:20
Options
Closing CBOE SPX and VIX Index summary for September 21st »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IMMU

Immunomedics

$11.45

0.01 (0.09%)

16:18
09/21/17
09/21
16:18
09/21/17
16:18
Syndicate
Breaking Syndicate news story on Immunomedics »

Immunomedics files 34.8M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.